*Hosted by Members for Members

*Complimentary networking event

*Come and go and build your network

*Get to know your host, Ave!

*Although the event is complimentary you must register to attend.

When: January 29, 2020
Where: Woodview Way, Malvern, PA 19355
Time: 4:30PM – 6:30PM

Click here to learn more about Ave – Malvern!

AVE Flexible-Stay Furnished Apartments & Luxury Apartments

Live better! AVE’s seven convenient locations in the Greater Philadelphia Area offer 1, 2 & 3 bedroom flexible-stay, fully furnished apartments that are perfect for individuals who are relocating, renovating, in between homes, or traveling on extended business. They also offer luxury apartments for discerning renters who desire carefree living year-round. Experience high-touch service from professional team members on site 7 days a week and unparalleled, on-demand amenities including resort pools, flex workspaces, state-of-the-art fitness centers, wellness classes, resident events, and more. Visit www.aveliving.com or call 267-400-1963.

Hear from the CEO of a pharma company working on synthetic cannabinoids, an investor actively seeking new investments in the legal cannabis market, and a pediatric neurologist managing clinical trials at CHOP, testing the efficacy of a cannabis extract for treating severe childhood epilepsy.  Attendees can enjoy the benefit of a Q+A interactive panel, breakfast, and networking with industry leaders.

Agenda

7:15 a.m. – 8:15 a.m.     Registration & Networking
8:15 a.m. – 9:30 a.m.     Panel Discussion

Speakers:

Armando Anido, Chairman and CEO, Zynerba Pharmaceuticals, Inc.

Armando Anido has served as our Chairman and Chief Executive Officer (CEO) since October 2014. Mr. Anido has more than 30 years of executive, operational and commercial leadership experience in the biopharmaceutical industry, particularly in leading CNS transdermal patch and gel products through the entire product life cycle. Prior to Zynerba, Mr. Anido served as CEO of two publicly traded companies. Most recently, he was the CEO of NuPathe (NASDAQ: PATH), which was acquired by Teva Pharmaceuticals in February 2014. At NuPathe, he led the company through FDA approval of its lead product, Zecuity®, the first transdermal patch for migraine, to pre-launch before successfully selling the company to Teva. He also served as President and CEO of Auxilium Pharmaceuticals (NASDAQ: AUXL), where under his leadership, sales grew from $42 million in 2005 to more than $260 million in 2011 and market capitalization increased from $200 million to more than $900 million. Prior to Auxilium, Mr. Anido served as Executive Vice President, Sales and Marketing, at MedImmune and prior to that, in senior sales and marketing positions at GlaxoWellcome and Lederle Laboratories. At GlaxoWellcome, he was Vice President, Central Nervous System Marketing, responsible for the commercialization of the epilepsy, migraine and depression businesses in the U.S. He is currently a member of the Board of Directors of Life Sciences Pennsylvania, and he was a member of the Board of Directors of Adolor until it was sold to Cubist in December 2011. Mr. Anido earned a BS in Pharmacy and an MBA from West Virginia University.

Howard Goodwin, M.D., Partner, Intrinsic Capital Partners

For the last 18 years, Dr. Goodwin has demonstrated a proven acumen investing in healthcare businesses at top investment firms, including Maverick Capital, Citadel Investments and, most recently, as a portfolio manager at Millennium Partners.  Dr. Goodwin began his investment career at Graham Partners, a middle-market private equity firm.  Prior to beginning his investment career, Dr. Goodwin received his medical degree from Thomas Jefferson University.

Intrinsic Capital Partners is an investment firm focused on life-science and technology businesses within the legal cannabis market. The Intrinsic team brings institutional investment discipline and world-class operating experience to build and scale industry-leading companies that address unmet needs across the supply chain.

Eric Marsh M.D., Ph.D., Associate Professor of Neurology and Pediatrics, Division of Neurology, Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania 

Dr. Marsh is a child neurologist at CHOP.  His clinical work centers around diagnosing and treating children with early onset epilepsy, brain malformations, and intellectual disabilities.  He is the director of the neurogenetics clinic.  His’s research program focuses on understanding how changes in brain development lead to epilepsy, intellectual disability, and autism. He combines molecular and physiological tools in mouse models to ask questions about the interaction of normal development with single gene mutations to determine how the brain responds to perturbations in development.  He has been involved, since the beginning of compassionate use and clinical trials with GW Pharma on Epidiolex, the purified CBD used for the treatment of intractable seizures.

The 2020 Annual Dinner is the premier event of the season for the life sciences industry in Pennsylvania. On March 19, 2020 more than 1,400 attendees will convene for this can’t-miss event.  We look forward to hosting industry and community leaders for an evening spent celebrating the successes of the past year.

Sponsorship Opportunities are available. For any additional questions or information, please contact Melissa Callum at mcallum@lifesciencespa.org.

*Following your purchase, you will receive an email confirming your purchase and steps on how to send over your table attendees.

CANCELLATION POLICY: Table purchases are non-refundable.  For Individual Tickets, please contact LSPA to request a refund.  As of COB Friday February 28, 2020 LSPA will no longer refund ticket purchases.

Health care businesses experiencing distress include for-profit and nonprofit hospitals, ambulatory care centers, skilled nursing facilities, home health providers, reference laboratories, and pharmaceutical and medical device manufacturers. In 2019, we saw a rapid rise in the pace of bankruptcy filings in the health care space, with more than 50 large businesses filing through Q3. Drivers of distress include increased regulatory oversight, reduced reimbursement rates, inability to achieve economies of scale, growing competition from hospital and health care giants, and liabilities related to the opioid crisis. This landscape presents both significant risks and — potentially — significant rewards. Companies need the knowledge and sophistication to protect themselves from the upstream and downstream impacts that customer and vendor bankruptcies may have on their organizations. At the same time, they should be aware of the opportunities for value investors, both strategic and financial, created by bankruptcy asset sales.

Join Pepper Hamilton partner Deborah Kovsky-Apap as she presents an overview of the bankruptcy process and provides guidance on avoiding the pitfalls and maximizing the opportunities in Chapter 11.

Program is approved for one (1) substantive MCLE credit in Pennsylvania. Attorneys licensed in New Jersey may claim credit under New Jersey’s reciprocity policy.

This event is sponsored by Pepper Hamilton’s Health Sciences Department, a team of 110 attorneys who collaborate across disciplines to solve complex legal challenges confronting clients throughout the health sciences spectrum.

Location

Philadelphia Country Club
1601 Spring Mill Road
Gladwyne, PA 19035

Registration

There is no cost to attend.

Contact Kim MacAlister at macalisterk@pepperlaw.com or 215.981.4249 with any questions.

Life Sciences Forum 2020: Focus on Parkinson’s Disease

Featured Panel Members
• Mr. Mark Frasier, Senior Vice President, Research Programs at The Michael J. Fox Foundation for Parkinson’s Research
• Dr. Jeremy Skillington, Vice President Business Development at Inflazome Ltd
• Mr. Jeff McGroarty, MBA, CPA, CFO of Annovis Bio
• Dr. Mary Ann Thenganatt, MD, Parkinson’s Disease & Movement Disorders Center, Department of Neurology, University of Pennsylvania Medicine
* additional panel members to be announced

Agenda
2.30 pm: Registration, Networking, Coffee/Tea Break
3.00 pm: Formal Program, Panel Discussion, Question & Answer Session
5.00 – 6.30 pm: Networking Reception (cocktails and hors d’oeuvre stations)

Location
The Union League of Philadelphia
Grant Ballroom, First Floor
140 South South Broad Street, Philadelphia, PA 19102

Parking & Directions
Please click HERE for more details.

Dress Code
Business attire

Registration 
• Tickets include one drink ticket and heavy hors d’oeuvres
• Members are welcome to register guests at the member rate.

Life Sciences PA members receive $50 off the non-member registration with code “LSPA”

Dan Diaz was not only a part of the industry for over 30 years, he has had an impact on many individuals’ lives. When Dan wanted to start this group, he decided on making it a unique club that would allow people to personally network with each other on a more regular basis. He created the “Doylestown Biotech Breakfast Club” which has since been renamed the “Dan Diaz Biotech Breakfast Club”. Before he got sick, he had one thing in mind and that was to create better health for the community and his passion for his work was unstoppable.

Dan was diagnosed with Bulbar ALS in early 2016. During this time, Dan fought a tough battle and passed away in April 2018. He went to a Breakfast Club meeting two weeks before he lost his battle, his passion for networking and work was shown through this along with many other events. If it wasn’t for the Philadelphia Chapter ALS Association his family wouldn’t have been given the resources to help them through such a tough time. In honor of Dan, we would like to give back to the ALS Association for families in our community along with the research that they fund. Please join us as we honor his life!

In support of the ALS Association Greater Philadelphia Chapter The Dan Diaz Biotech Breakfast Club in partnership with the Pennsylvania Biotechnology Center of Bucks County will host its 2nd annual fundraising reception. Our goal is to raise funds and awareness for ALS research. The evenings events include:

Opening Remarks by Lou Kassa COO of the Biotechnology Center

Remarks Katie Diaz 

Speech by Ellyn C. Phillips President ALS Association Greater Philadelphia Chapter

50/50 with cash prizes

The event is free but a $20 donation for the evening is recommended and will be directly contributed to the ALS Association Greater Philadelphia Chapter.

For sponsorship inqiuries contact Robb Hoyle rhoyle@gtscareers.com

Thank you to our event sponsors:

Citi Bank

Pennsylvania Biotechnology Center

StraNexa BioPharm Commercialization Consultancy, LLC

Fox Chase Chemical Diversity Center

Can’t attend but still want to donte? Donate Here

With drug prices a topic of public debate, every day seems to bring new proposals on the issue. Recent and proposed drug pricing actions at the federal level include bills in Congress, regulatory changes and major litigation. State lawmakers increasingly are turning their attention to drug prices as well, with potentially significant implications — and the marketplace is not standing still.

Pepper partner Allan A. Thoen and Yvonne Clark, director and counsel in the commercial legal group at Merck & Co., will cut through the headline noise and provide an overview of the major concepts and proposals in play. This presentation will also highlight some innovative commercial arrangements that have emerged recently in response to concerns over drug prices.

Program is approved for one (1) substantive MCLE credit in Pennsylvania. Attorneys licensed in New Jersey may claim credit under New Jersey’s reciprocity policy.

This event is sponsored by Pepper Hamilton’s Health Sciences Department, a team of 110 attorneys who collaborate across disciplines to solve complex legal challenges confronting clients throughout the health sciences spectrum.

Location

Philadelphia Country Club
1601 Spring Mill Road
Gladwyne, PA 19035

Registration

There is no cost to attend.

Contact Kim MacAlister at macalisterk@pepperlaw.com or 215.981.4249 with any questions.